We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRNA
2026
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.57M | ﹤0.01% |
77,944
-1,119
| -1% | -$30.9K |
|
2027
OneSpan
OSPN
$618M
| $1.56M | ﹤0.01% |
83,225
-11,511
| -12% | -$244K |
|
|
AIV
2028
Aimco
AIV
$383M
| $1.56M | ﹤0.01% |
227,202
+4,022
| +2% | +$27.7K |
|
2029
StepStone Group
STEP
$3.82B
| $1.55M | ﹤0.01% |
36,336
+4,048
| +13% | +$179K |
|
|
IMGN
2030
DELISTED
Immunogen Inc
IMGN
| $1.54M | ﹤0.01% |
271,606
+4,587
| +2% | +$26.5K |
|
|
RDUS
2031
DELISTED
Radius Recycling
RDUS
| $1.54M | ﹤0.01% |
35,131
+1,269
| +4% | +$61.3K |
|
2032
BellRing Brands
BRBR
$1.34B
| $1.53M | ﹤0.01% |
49,774
+1,505
| +3% | +$48.2K |
|
|
FFWM
2033
DELISTED
First Foundation Inc
FFWM
| $1.53M | ﹤0.01% |
58,044
+1,285
| +2% | +$30.7K |
|
2034
Talos Energy
TALO
$2.4B
| $1.53M | ﹤0.01% |
110,872
+477
| +0.4% | +$5.81K |
|
|
PRO
2035
DELISTED
PROS Holdings
PRO
| $1.52M | ﹤0.01% |
42,933
+1,484
| +4% | +$62.3K |
|
|
VCRA
2036
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $1.52M | ﹤0.01% |
33,163
+1,784
| +6% | +$79.6K |
|
2037
Northern Oil and Gas
NOG
$2.35B
| $1.51M | ﹤0.01% |
70,696
+3,479
| +5% | +$60.8K |
|
|
ROCC
2038
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $1.51M | ﹤0.01% |
56,613
-4,163
| -7% | -$81.9K |
|
2039
Codexis
CDXS
$158M
| $1.51M | ﹤0.01% |
64,780
+2,612
| +4% | +$61.8K |
|
|
DCPH
2040
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.5M | ﹤0.01% |
44,303
+1,227
| +3% | +$39.2K |
|
|
HT
2041
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $1.5M | ﹤0.01% |
161,266
-19,799
| -11% | -$188K |
|
|
LL
2042
DELISTED
LL Flooring Holdings, Inc.
LL
| $1.5M | ﹤0.01% |
80,528
-9,852
| -11% | -$194K |
|
2043
Tootsie Roll Industries
TR
$2.98B
| $1.5M | ﹤0.01% |
57,000
-2,459
| -4% | -$69.3K |
|
2044
German American Bancorp
GABC
$1.9B
| $1.49M | ﹤0.01% |
38,664
-8,325
| -18% | -$310K |
|
2045
ATN International
ATNI
$492M
| $1.49M | ﹤0.01% |
31,837
-3,763
| -11% | -$170K |
|
|
SHOE
2046
Shoe Station Group
SHOE
$428M
| $1.49M | ﹤0.01% |
46,012
-6,082
| -12% | -$212K |
|
2047
Amphastar Pharmaceuticals
AMPH
$916M
| $1.49M | ﹤0.01% |
78,426
-12,900
| -14% | -$253K |
|
|
EBSB
2048
DELISTED
Meridian Bancorp, Inc.
EBSB
| $1.49M | ﹤0.01% |
71,758
+2,125
| +3% | +$42.3K |
|
|
BFS
2049
Saul Centers
BFS
$841M
| $1.49M | ﹤0.01% |
33,777
-4,888
| -13% | -$220K |
|
2050
Gogo Inc
GOGO
$492M
| $1.48M | ﹤0.01% |
85,662
+2,775
| +3% | +$33.6K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.